Why “reprogramming” is the buzziest approach to reversing aging right now

Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…

This report comes from MIT Tech Review. The story centres on Why “reprogramming” is the buzziest approach to reversing aging right now. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from MIT Tech Review and related outlets covering this beat.